Item 5. Other Information
ITEM 5. OTHER INFORMATION
On March 13, 2025 , Marc Benathen ,
Chief Financial Officer , adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c)
for the sale of up to 200,000 shares of the Company’s common stock, at various limit prices above the current market price of the
Company’s common stock as of the plan adoption date, with such transactions to occur during sale periods beginning on or after June
13, 2025 and ending on the earlier of May 31, 2026 or the date on which all shares authorized for sale have been sold in conformance with
the terms of the arrangement.
On
March 13, 2025 , Nicholas Alvarez , Chief Acquisition Officer , adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the
affirmative defense of Rule 10b5-1(c) for the sale of up to 300,000 shares of the Company’s common stock, at various limit prices
above the current market price of the Company’s common stock as of the plan adoption date, with such transactions to occur during
sale periods beginning on or after July 1, 2025 and ending on the earlier of April 10, 2026 or the date on which all shares authorized
for sale have been sold in conformance with the terms of the arrangement.
33
ITEM 6. EXHIBITS
Incorporated by Reference
Exhibit Number
Exhibit Description
Form
Exhibit
Filing Date/Period End Date
31.1*
Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.
31.2*
Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer.
32.1**
Section 1350 Certification of Chief Executive Officer.
32.2**
Section 1350 Certification of Chief Financial Officer.
101.INS*
Inline XBRL Instance Document
101.SCH*
Inline XBRL Taxonomy Extension Schema Document
101.CAL*
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS)
* Filed herewith.
**Furnished herewith
34
SIGNATURES
Pursuant to the requirements of
Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
LIFEMD, INC.
By:
/s/ Justin Schreiber
Justin Schreiber
Chief Executive Officer and Chairman of the Board of Directors
(principal executive officer)
Date:
May 6, 2025
By:
/s/ Marc Benathen
Marc Benathen
Chief Financial Officer
(principal financial officer)
Date:
May 6, 2025
By:
/s/ Maria Stan
Maria Stan
Chief Accounting Officer and Controller
(principal accounting officer)
Date:
May 6, 2025
35
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.